DuoDote.com

E-mail: send a message directly to info@meridianmt.com, customerservice@meridianmt.com, or fill out the form at the bottom of this page and we will respond to your questions promptly.

Phone: 800.638.8093 or 443.259.7800
Fax: 443.259.7801

Corporate Offices

MERIDIAN MEDICAL TECHNOLOGIES™, INC.
A wholly owned subsidiary of King Pharmaceuticals^®, Inc.
KING PHARMACEUTICALS^®, INC.
501 Fifth Street
Bristol, Tennessee 37620
Phone: 800.776.3637
http://www.kingpharm.com

Information Request Form:
Fields marked with an (*) are required.

*First Name
*Last Name
*E-mail
Organization
Title
Mailing Address
City
State
Zip Code
Phone
Fax
Preferred method of contact
What kind of information do you need?
Question or comment here (max. 200 words)

The DuoDote™ Auto-Injector (atropine 2.1 mg/0.7 mL and pralidoxime chloride 600 mg/2 mL) is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides.

IMPORTANT SAFETY INFORMATION

The DuoDote Auto-Injector is intended as an initial treatment of the symptoms of organophosphorus insecticide or nerve agent poisonings; definitive medical care should be sought immediately. The DuoDote Auto-Injector should be administered by Emergency Medical Services personnel who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication.

Individuals should not rely solely upon agents such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments including masks designed specifically for this use. Evacuation and decontamination procedures should be undertaken as soon as possible. Medical Personnel assisting evacuated victims of nerve agent poisoning should avoid contaminating themselves by exposure to the victim's clothing.

In the presence of life-threatening poisoning by organophosphorus nerve agents or insecticides, there are no absolute contraindications to the use of the DuoDote Auto-Injector. When symptoms of poisoning are not severe, DuoDote Auto-Injector should be used with extreme caution in people with heart disease, arrhythmias, recent myocardial infarction, severe narrow angle glaucoma, pyloric stenosis, prostatic hypertrophy, significant renal insufficiency, chronic pulmonary disease, or hypersensitivity to any component of the product.

Please click here to view full prescribing information for DuoDote.

© 2007 Meridian Medical Technologies™ Inc., a subsidiary of King Pharmaceuticals^®, Inc. DuoDote™ Auto-Injector, the DuoDote logo, BinaJect™, and Mark I™ Kit are trademarks of Meridian Medical Technologies™, Inc. AtroPen^® is a registered trademark of Meridian Medical Technologies™, Inc. MMT 4908 10/07^®